Clinical relevance of serum nortriptyline and 10-Hydroxy-Nortriptyline measurements in the depressed elderly: A multicenter pharmacokinetic and pharmacodynamic study

Neuropsychopharmacology

Volumn 15, Issue 1, 1996, Pages 1-6

  Ng Ying Kin, N M K ^a   Klitgaard, N ^b   Nair, N P V ^a   Amin, M ^a   Kragh Sorensen, P ^b   Schwartz, G ^a   Ahmed, S K ^a   Holm, P ^c   Katona, C ^d   Stage, K ^b  

^a MCGILL UNIVERSITY   (Canada)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Pharma Marketing   (Denmark)

^d PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

10 Hydroxynortriptyline; Anticholinergic side effects; Blood levels; Efficay; Geriatric depression; Nortriptyline

Indexed keywords

10 HYDROXYNORTRIPTYLINE; NORTRIPTYLINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; GERONTOPSYCHIATRY; HUMAN; HYPERTENSION; LEG EDEMA; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; SIDE EFFECT;

EID: 8944262827     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00142-Z     Document Type: Article

References (26)

1. American Psychiatric Association (1987): Diagnostic and statistical manual of mental disorders, ed. 3, rev. Washington, DC, American Psychiatric Association
2. Asberg M, Cronholm B, Sjoqvist F, Tuck D (1971): Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3:331-334
3. Bech P (1981): Rating scales for affective disorders: Their validity and consistency. Acta Psychiatr Scand 64 (suppl 295):1-101
4. Bertilsson E, Mellstrom B, Sjoqvist F (1979): Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptyline. Life Sci 25:1285-1292
5. Dawling S, Crome P, Braithwaite R (1980): Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers. Clin Pharmacokinetics 5:394-401
6. Georgotas A, McCue RE, Hapworth W, Friedman E, Kim OM, Welkowitz J, Chang I, Cooper TB (1986): Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biol Psychiatry 21:1155-1166
7. Georgotas A, McCue RE, Cooper T, Chang I, Mir P, Welkowitz R (1987a): Clinical predictions of response to antidepressants in elderly patients. Biol Psychiatry 22:733-740
8. Georgotas A, McCue RE, Friedman E, Cooper TB (1987b): Response of depressive symptoms to nortriptyline, phenelzine and placebo. Br J Psychiatry 151:102-106
9. Gram LF, Brosen K, Kragh-Sorensen P, Christensen P (1989): Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: Significance of concurrent medication and the sparteine oxidation type. Ther Drug Monit 11(5):508-514
10. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
11. Kanba S, Matsumoto K, Nibuya M, Suzuki E, Kinoshita N, Shintani F, Yagi G (1992): Nortriptyline response in elderly depressed patients. Prog Neuro Psychopharmacol Biol Psychiatry 16:301-309
12. Katz IR, Simpson GM, Jethanandani V, Cooper T, Muhly C (1989): Steady state pharmacokinetics of nortriptyline in the frail elderly. Neuropsychopharmacology 2:229-236
13. Kiltgaard NA (1977): Determination of therapeutic concentrations of doxepin and desmethyldoxepin in human serum by high performance liquid chromatography. Arch Pharm Chem Sci Ed 5:61-66
14. Kragh-Sorensen P, Larsen N-E (1980): Factors influencing nortriptyline steady-state kinetics: Plasma and saliva levels. Clin Pharmacol Therap 28:796-803
15. Kragh-Sorensen P, Asberg M, Hansen E (1973): Plasma nortriptyline levels in endogenous depression. Lancet 1:113-115
16. McCue RE, Georgotas A, Nagachandran N, Basir MA, Go EA, Suckow RF, Cooper TB (1989): Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed. J Psychiatr Res 23:73-79
17. Miller MD, Pollock BG, Rifai AH, Paradis CF, Perel JM, George C, Stack JA, Reynolds CF III (1991): Longitudinal analysis of nortriptyline side effects in elderly depressed patients. J Geriatr Psychiatry Neurol 4:226-230
18. Nair NPV, Amin M, Holm P, Katona C, Klitgaard N, Ng Ying Kin NMK, Kragh-Sorensen P, Kuhn H, Leek CA, Stage KB (1995): Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo. J Affect Dis 33(1):1-9
19. Nilvebrant L, Nordin C (1991): Affinity of nortriptyline and its E-10-hydroxy metabolite for muscarinic receptors. Pharmacol Toxicol 68(1):64-67
20. Nordin C, Bertilsson L, Dahl M-L, Resul B, Toresson G, Sjoqvist F (1991): Treatment of depression with E-10-hydroxynortriptyline - A pilot study on biochemical effects and pharmacokinetics. Psychopharmacology 103:287-290
21. Potter WZS, Rudorfer MV, Manji H (1991): The pharmacologic treatment of depression. N Eng J Med 325:633-642
22. Rafaelson OJ, Clemmesen L, Lund H, Mikkelsen PL, Bolwig TG (1981): Comparison of peripheral anti-cholinergic effects of antidepressants: Dry mouth. Recent advances in the treatment of depression. Acta Psychiatr Scand 63:364-369
23. Rubin EH, Bigss JT, Preskorn SH (1985): Nortriptyline pharmacokinetics and plasma levels: Implications for clinical practice J Clin Psychiatry 46:418-424
24. Young RC, Alexopoulos GC, Shamoian CA, Manley MW, Dhar AK, Kuff H (1984): Plasma-10-hydroxy-nortriptyline in elderly depressed patients. Clin Pharmacol Ther 35:540-544
25. Young RC, Alexopoulos GC, Shamoian CA, Kitt H (1985): Plasma-10-hydroxy-nortriptyline and EKG changes in elderly depressed patients. Am J Psychiatry 142:866-868
26. Young RC, Alexopoulos GC, Dhar AK, Kuff H (1987): Plasma 10-hydroxy-nortriptyline renal function in elderly depressives. Biol Psychiatry 22:1283-1287